RBC Bioscience

RBC Bioscience Interest Expense

The Interest Expense of RBC Bioscience (6848.TWO) as of Oct 21, 2026 is -9.80 M TWD. In the previous year, Interest Expense was -9.64 M TWD — a change of 1.69% (lower).

Interest Expense

-9.80 MTWD

YoY

1.69%

Last updated:

Interest Expense of RBC Bioscience is 2024 -9.80 M TWD. Interest Expense of RBC Bioscience was 2023 -9.64 M TWD. It decreases by 1.69% lower compared to the previous year.

The RBC Bioscience Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2018
1.63 M TWD
Jan 1, 2019
-869,000.00 TWD
Jan 1, 2020
-1.05 M TWD
Jan 1, 2021
-6.15 M TWD
Jan 1, 2022
-7.41 M TWD
Jan 1, 2023
-9.64 M TWD
Jan 1, 2024
-9.80 M TWD
The RBC Bioscience Interest Expense history
YEARInterest ExpenseYoY
-9.80 MTWD+1.69%
-9.64 MTWD+30.04%
-7.41 MTWD+20.47%
-6.15 MTWD+488.90%
-1.05 MTWD+20.25%
-869,000.00TWD-153.28%
1.63 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Interest Expense of RBC Bioscience is -9.80 M TWD in 2024.

Interest Expense of RBC Bioscience changed from -9.64 M TWD to -9.80 M TWD, representing a 1.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — RBC Bioscience

All Key Metrics — RBC Bioscience